Compare ATR & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATR | BIRK |
|---|---|---|
| Founded | 1992 | 1774 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Plastic Products | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 7.9B |
| IPO Year | 1993 | 2023 |
| Metric | ATR | BIRK |
|---|---|---|
| Price | $125.57 | $39.61 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 14 |
| Target Price | ★ $167.50 | $63.23 |
| AVG Volume (30 Days) | 389.9K | ★ 2.8M |
| Earning Date | 02-05-2026 | 02-12-2026 |
| Dividend Yield | ★ 1.54% | N/A |
| EPS Growth | 24.99 | ★ 83.10 |
| EPS | ★ 6.23 | 2.19 |
| Revenue | ★ $3,662,533,000.00 | $2,460,904,611.00 |
| Revenue This Year | $3.97 | $14.14 |
| Revenue Next Year | $3.36 | $14.62 |
| P/E Ratio | $19.99 | ★ $18.36 |
| Revenue Growth | 2.50 | ★ 16.22 |
| 52 Week Low | $103.23 | $36.89 |
| 52 Week High | $164.28 | $62.66 |
| Indicator | ATR | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 56.69 | 43.21 |
| Support Level | $123.24 | $36.89 |
| Resistance Level | $126.41 | $40.53 |
| Average True Range (ATR) | 2.77 | 1.92 |
| MACD | 0.15 | -0.31 |
| Stochastic Oscillator | 81.74 | 34.27 |
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, closures, and elastomer packaging components to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (49% of sales) and the United States (32%), Aptar aims to increase its presence in Asia (11%) and Latin America (8%). It operates three business segments, Pharma, Beauty, and Closures. Pharma generates over two thirds of group profits.
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.